Similar articles

• Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.

  Corradi HR, Schwager SL, Nchinda AT, Sturrock ED, Acharya KR. Corradi HR, et al. J Mol Biol. 2006 Mar 31;357(3):964-74. doi: 10.1016/j.jmb.2006.01.048. Epub 2006 Jan 31. J Mol Biol. 2006. PMID: 16476442
• Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.

  Natesh R, Schwager SL, Sturrock ED, Acharya KR. Natesh R, et al. Nature. 2003 Jan 30;421(6922):551-4. doi: 10.1038/nature01370. Epub 2003 Jan 19. Nature. 2003. PMID: 12540854
• Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors.

  Gomez C, Berteina-Raboin S, De Nanteuil G, Guillaumet G. Gomez C, et al. Bioorg Med Chem. 2013 Nov 15;21(22):7216-21. doi: 10.1016/j.bmc.2013.08.032. Epub 2013 Sep 11. Bioorg Med Chem. 2013. PMID: 24095015
• Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene.

  Soubrier F, Hubert C, Testut P, Nadaud S, Alhenc-Gelas F, Corvol P. Soubrier F, et al. J Hypertens. 1993 May;11(5):471-6. doi: 10.1097/00004872-199305000-00001. J Hypertens. 1993. PMID: 8390518 Review. No abstract available.
• The angiotensin I-converting enzyme (kininase II): molecular and regulatory aspects.

  Jaspard E, Costerousse O, Wei L, Corvol P, Alhenc-Gelas F. Jaspard E, et al. Agents Actions Suppl. 1992;38 ( Pt 1):349-58. doi: 10.1007/978-3-0348-7321-5_44. Agents Actions Suppl. 1992. PMID: 1334621 Review. No abstract available.